NRXP$2.28+4.85%
NRX Pharmaceuticals, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$98.51M
Float & O/S:41.51M / 43.3M
Inst Own:27.5%
DilutionScan read 30 of NRX Pharmaceuticals, Inc.'s SEC filings and found 16 warrant series, 4 convertibles, 1 ATM program, 2 shelf registrations, 1 S-1 registration and 3 completed offerings on file for NRXP. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
